Agoracom: Small Cap Investment - Resverlogix Corp. - Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

sumpup

Rank: Treasurer [?]

Points: 264 [?]

Votes: 9 Score: 3.1 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

in response to

Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial

ImmunoSupremo

posted on Dec 22, 2020 04:37PM

https://www.youtube.com/watch?v=eK0C5tFHze8&t=834s

A nice little piece dumbed down by an expert on how mRNA works, the answers basic questions people would ask

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply